Ching-An Peng

Ching-An Peng is a Professor in the Department of Chemical & Biological Engineering at the University of Idaho. He holds a Ph.D. from the University of Michigan (1995), an M.S. from the University of Notre Dame (1990), and a B.S. from National Taiwan University (1985). His research focuses on drug/gene delivery systems, nano-bio technologies, and cellular/tissue engineering. Key projects include developing CD47-functionalized nanoparticles to evade immune detection, photothermolysis-based cancer therapies using nanomaterials, and novel drug delivery platforms leveraging mesenchymal stem cells.

• Education:
  • Ph.D., Chemical Engineering, University of Michigan, 1995
  • M.S., Chemical Engineering, University of Notre Dame, 1990
  • B.S., Chemical Engineering, National Taiwan University, 1985

His research interests span drug delivery (e.g., polymeric micelles for anticancer therapies), nanotechnology (carbon nanotubes, gold nanorods for targeted photothermal ablation), and biomedical engineering (mesenchymal stem cell-based therapies, immune-modulating carriers). Recent work includes抗疫 strategies against SARS-CoV-2 using ACE2-functionalized nanoparticles and photothermal agents.

Publications highlight advancements in nanomaterial-based therapies, including antiviral drug screening using quantum dot-virus complexes and engineered algal systems for high-value compound production. Collaborations emphasize translational applications of nanotechnology in healthcare.

His lab integrates engineering principles with biology to address challenges in regenerative medicine, cancer treatment, and infectious disease control. Ongoing efforts focus on optimizing CD47-functionalized carriers and developing plant-derived prodrug systems.